New Research Reveals Novel Method to Starve Prostate Cancer Tumors
/0 Comments/in Preclinical Research/by MaxGenomenon Unveils Groundbreaking Genomic Knowledgebase Powered by AI
/0 Comments/in Artificial Intelligence/by MaxDinuclear Platinum(II) Complexes: A Promising New Chemotherapy to Treating Prostate Cancer
/0 Comments/in Chemotherapy, Preclinical Research/by MaxNewsletter 5
/0 Comments/in Newsletter/by MaxLAST WEEK TODAY! A summary of what was published on ProstateWarriors.com during the past week Here I am with the fifth newsletter from the site. I hope I will be like Santa Prostate and bring you some exciting discovery by Christmas! We also have a podcast if you prefer to listen to the newsletter, you can find it […]
Hijacking the Brakes: Scientists Uncover Prostate Cancer’s Growth Secret
/0 Comments/in CRISPR, Preclinical Research/by MaxDietary Intervention Shows Promise in Slowing Prostate Cancer Progression
/0 Comments/in Clinical Trial, Localized/by MaxInvikafusp Alfa: New Hope for Advanced, Anti-PD-1 Resistant Cancers Phase 1 and 2 Trial
/0 Comments/in Clinical Trial, Metastatic, Phase 1, Phase 2/by MaxA New Hope for Hard-to-Treat Cancers: a New TACC3 Inhibitor
/0 Comments/in Clinical Trial, Not PCa related/by MaxTiny Robots Revolutionize Targeted Drug Delivery: Caltech’s Microscopic Marvels
/0 Comments/in Delivery, Preclinical Research/by MaxProject Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
225Ac abiraterone acetate ADC ADT AI ai in healthcare antibody-drug conjugate apalutamide ASCO 2025 ATM bispecific antibody bone metastases bone metastasis BRCA cancer immunotherapy castration-resistant prostate cancer CDK12 clinical trial clinical trials crispr CYP11A1 inhibitor darolutamide drug repurposing drug resistance enzalutamide HRR immune checkpoint inhibitors immunotherapy mcrpc metastatic castration-resistant prostate cancer metastatic hormone-sensitive prostate cancer mHSPC mRNA nanotechnology olaparib oncolytic virus personalized medicine prostate cancer protac PSMA radioligand therapy radiopharmaceuticals real-world data T-cell therapy theranostics
Latest Posts
- Newsletter 23/2025 June 8, 2025
- Protein Design Leaps Forward Thanks to AI June 5, 2025
- Phase 1 Trial of XL309: USP1 Inhibitor Targeting DNA Repair in Solid Tumors June 5, 2025
- UPDATE About ACE-232: Phase 1 Trial of a Novel CYP11A1 Inhibitor for mCRPC June 5, 2025